Skip to content
SigiPulse
All trends
general·Emerging

Fresenius and WuXi team up in 37

Detected 1h 38m ago·2 sources·🌍·Peaks in ~36h
Personalize this

Get Personalized Trend Intelligence

Pulse will surface trends in your niche, ranked by opportunity — not generic feeds.

Start free
Viral Score
36/100
42% confidence
Controversy
0/100
Low risk
Opportunity
61/100
Content potential
📡Mentions this hour
2
📰Publishers
2
🔥Engagement
25/100
⏱Window left
~36h

Why It's Trending

AI

[Pharma] The deal covers assets that target more than €370bn in originator sales. [Pharma] Fresenius gets option rights on up to 37 first-to-market biosimilar candidates developed by WuXi Biologics, starting with copies of Roche's Polivy and Amgen's Tepezza. Fresenius picks the programs and keeps t…

Powered by SigiPulse · Sourced from pharmaceutical-technology.com, drugdiscoverytrends.com

Audience Sentiment

67% Positive12% Neutral21% Negative

Predominantly positive. Safe to post.

Trend Lifecycle

1
Emerging
2
Growing
3
Viral
4
Peak
5
Declining
6
Dead
Expected peak in ~36h17%

Score History

Last 12 hours
Viral scoreControversy

Platform Breakdown

News outlets100%

Geographic Reach

🌍 Global — no single country dominates this trend.

Content Ideas

48+ ideas
reels hook

POV: You're watching Fresenius and WuXi team up in 37 unfold live

Low engagement
reels hook

Fresenius and WuXi team up in 37 — explained in 60 seconds

Medium engagement
reels hook

Where were you when Fresenius and WuXi team up in 37 happened?

High engagement
reels hook

The moment everyone missed about Fresenius and WuXi team up in 37

Low engagement
reels hook

Fresenius and WuXi team up in 37: the timeline nobody is talking about

Medium engagement
reels hook

What Fresenius and WuXi team up in 37 actually means for the next 24 hours

High engagement

Linked Sources

More like this

Unlock More Opportunities Like This

Members see the full set of related trends, AI briefs, and a personalized daily digest.

Unlock for free

More general trends

View all
Free forever — no card

Create your free account

Stop browsing trends. Start acting on them — with AI briefs tuned to your niche.

Create free account